PDL BioPharma Liquidation May Offer 40% Upside For Patient Investors Comfortable With Illiquidity
PDL BioPharma Reschedules Third Quarter 2020 Financial Results and Business Update
The Daily Biotech Pulse: CureVac Close To Coronavirus Vaccine Deal With EU, Entera Bio's Positive Readout, Patent Protection For Co-Diagnostics
The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs
The Daily Biotech Pulse: Poseida's Phase 1 Study Placed On Clinical Hold, Orphan Drug Designation For Krystal Biotech, Tiziana's Patent Award
The Daily Biotech Pulse: Novavax Vaccine Deals, Trevena Awaits FDA Decision, 2 IPOs
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
A Stock-Picker's Guide To Benjamin Graham's Screening Rules
Invesco Ltd. Reduces Stake in PDL BioPharma Inc (NASDAQ:PDLI)
Legal & General Group Plc Reduces Stock Holdings in PDL BioPharma Inc (NASDAQ:PDLI)
Two Sigma Investments LP Makes New $103,000 Investment in Golden Entertainment Inc (NASDAQ:GDEN)
Guggenheim Capital LLC Cuts Holdings in Park Electrochemical Corp. (NYSE:PKE)
Skandinaviska Enskilda Banken AB publ Has $3.53 Million Stake in Apollo Global Management LLC (NYSE:APO)
Morgan Stanley Purchases 1,359,007 Shares of Ferro Co. (NYSE:FOE)
AcelRx: Clever Solution To Painful Problem (NASDAQ:ACRX)
Mackenzie Financial Corp Boosts Position in Apple Inc. (NASDAQ:AAPL)
Ardagh Group SA (NYSE:ARD) Receives Average Recommendation of “Hold” from Analysts
Balyasny Asset Management LLC Invests $636,000 in StoneCo Ltd (NASDAQ:STNE)
New images show how two of Coventry’s oldest streets will be transformed
Two of Coventry's oldest streets to be transformed
Balyasny Asset Management LLC Purchases New Position in Zuora Inc (NYSE:ZUO)
United Capital Financial Advisers LLC Buys 1,025 Shares of Brunswick Co. (NYSE:BC)
Short Interest in Atlantic Capital Bancshares Inc (NASDAQ:ACBI) Rises By 5.1%
Apollo Global Management (NYSE:APO) Reaches New 52-Week High at $54.95
Investment Analysts’ Weekly Ratings Changes for Lawson Products (LAWS)
Henchy R. Enden Acquires 1,000 Shares of Atlantic Capital Bancshares Inc (NASDAQ:ACBI) Stock
13,082 Shares in PDL BioPharma Inc (NASDAQ:PDLI) Purchased by Cambridge Investment Research Advisors Inc.
The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive
The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering
Edited Transcript of PDLI earnings conference call or presentation 7-May-20 8:30pm GMT
PDL BioPharma's (PDLI) CEO Dominique Monnet on Q1 2020 Results - Earnings Call Transcript
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
Financial Contrast: PDL BioPharma (NASDAQ:PDLI) versus Idera Pharmaceuticals (NASDAQ:IDRA)
Head to Head Analysis: Replimune Group (NASDAQ:REPL) and PDL BioPharma (NASDAQ:PDLI)
Geode Capital Management LLC Sells 71,944 Shares of PDL BioPharma Inc (NASDAQ:PDLI)
PDL BioPharma Inc (NASDAQ:PDLI) Short Interest Down 14.0% in March
35,935 Shares in PDL BioPharma Inc (NASDAQ:PDLI) Purchased by Cubist Systematic Strategies LLC
Head-To-Head Contrast: Autolus Therapeutics (NASDAQ:AUTL) vs. PDL BioPharma (NASDAQ:PDLI)
Why Is PDL BioPharma (PDLI) Up 4.6% Since Last Earnings Report?
Why Is PDL BioPharma (PDLI) Up 4.6% Since Last Earnings Report?
PDL BioPharma Inc (NASDAQ:PDLI) Shares Bought by Credit Suisse AG
PDL BioPharma (NASDAQ:PDLI) Downgraded by TheStreet
PDL BioPharma Inc (NASDAQ:PDLI) Position Cut by Connor Clark & Lunn Investment Management Ltd.
Edited Transcript of PDLI earnings conference call or presentation 11-Mar-20 8:30pm GMT
AQR Capital Management LLC Has $7.25 Million Stake in PDL BioPharma Inc (NASDAQ:PDLI)
ProShare Advisors LLC Lowers Position in PDL BioPharma Inc (NASDAQ:PDLI)